BIRC5 and prostate carcinoma: Previous studies showed that BIRC5 or known as survivin, was highly expressed in various cancer cells, including lung cancer (86% expression), prostate cancer (71% expression), ovary cancer (29-85%), breast cancer (71-90%) and gastric cancer (35-68%) whereas in normal adult tissues this gene was expressed at a low level 37.